Minocycline as an adjunct for treatment-resistant depressive symptoms: a pilot randomised placebo-controlled trial MI Husain, IB Chaudhry, N Husain, AB Khoso, RR Rahman, MM Hamirani, ... Journal of Psychopharmacology 31 (9), 1166-1175, 2017 | 131 | 2017 |
Minocycline as an adjunct for treatment-resistant depressive symptoms: study protocol for a pilot randomised controlled trial MI Husain, IB Chaudhry, RR Rahman, MM Hamirani, I Qurashi, AB Khoso, ... Trials 16, 1-5, 2015 | 37 | 2015 |
A randomised clinical trial of methotrexate points to possible efficacy and adaptive immune dysfunction in psychosis IB Chaudhry, MO Husain, AB Khoso, MI Husain, MH Buch, T Kiran, B Fu, ... Translational psychiatry 10 (1), 415, 2020 | 29 | 2020 |
An evaluation of subjective experiences, effects and overall satisfaction with clozapine treatment in a UK forensic service I Qurashi, P Stephenson, S Chu, C Duffy, N Husain, I Chaudhry Therapeutic advances in psychopharmacology 5 (3), 146-150, 2015 | 27 | 2015 |
Promising use of minocycline augmentation with clozapine in treatment-resistant schizophrenia I Qurashi, JD Collins, IB Chaudhry, N Husain Journal of Psychopharmacology 28 (7), 707-708, 2014 | 24 | 2014 |
Reduction in the use of seclusion in a high secure hospital: A retrospective analysis I Qurashi, D Johnson, J Shaw, B Johnson Journal of Psychiatric Intensive Care 6 (2), 109-115, 2010 | 21 | 2010 |
A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol I Qurashi, IB Chaudhry, AB Khoso, S Farooque, S Lane, MO Husain, ... Trials 18, 1-9, 2017 | 16* | 2017 |
A diagnostic system using broad categories with clinically relevant specifiers: lessons for ICD-11 D Kingdon, S Afghan, R Arnold, R Faruqui, T Friedman, I Jones, P Jones, ... International journal of social psychiatry 56 (4), 326-335, 2010 | 16 | 2010 |
Changes in smoking status, mental state and plasma clozapine concentration: retrospective cohort evaluation I Qurashi, P Stephenson, C Nagaraj, S Chu, R Drake, L Couchman, ... BJPsych Bulletin 43 (6), 271-274, 2019 | 11 | 2019 |
Glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of hypersalivation induced by clozapine (GOTHIC1): study protocol for a randomised controlled … I Qurashi, S Chu, N Husain, RJ Drake, I Chaudhry, JFW Deakin Trials 17, 1-9, 2016 | 10 | 2016 |
Facial emotion recognition and sleep in mentally disordered patients: A natural experiment in a high security hospital S Chu, K McNeill, JL Ireland, I Qurashi Psychiatry Research 230 (2), 725-727, 2015 | 7 | 2015 |
Sections 37/41 Mental Health Act 1983: a study of judges' practice and assessment of risk to the public I Qurashi, J Shaw Medicine, Science and the Law 48 (1), 57-63, 2008 | 7 | 2008 |
A natural study of the efficacy of replacement medications for the treatment of clozapine-induced hypersalivation S Chu, I Qurashi, N Campbell, P Stephenson, R Massey, R Drake, ... Therapeutic advances in psychopharmacology 6 (2), 147-148, 2016 | 6 | 2016 |
Risperidone Long‐acting Injection (RLAI)–real world outcomes from the United Kingdom high‐secure hospitals S Gibbon, E Silva, R Kaler, I Qurashi, M Das, J Patrick, M Gahir, D Gray, ... The British Journal of Forensic Practice 13 (4), 264-269, 2011 | 6 | 2011 |
A career in forensic psychiatry⇓ I Qurashi BMJ 329 (7459), s33-s34, 2004 | 4 | 2004 |
The clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): a randomised placebo-controlled trial MJ Crawford, VC Leeson, R Evans, B Barrett, A McQuaid, J Cheshire, ... Therapeutic advances in psychopharmacology 12, 20451253221090832, 2022 | 2 | 2022 |
Glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of hypersalivation induced by clozapine (GOTHIC1): a feasibility study I Qurashi, S Chu, R Drake, V Hartley, I Chaudhry, JFW Deakin, N Husain Pilot and Feasibility Studies 5, 1-10, 2019 | 2 | 2019 |
Selective benefit of low dose methotrexate on positive symptoms of Schizophrenia in a randomized Double-Blind Placebo-Controlled 12-Week Feasibility Trial I Chaudhry, N Husain, T Kiran, MO Husain, A Khosu, RU Rahman, ... Neuropsychopharmacology 41, S228-S228, 2016 | 2 | 2016 |
Correction: A randomised clinical trial of methotrexate points to possible efficacy and adaptive immune dysfunction in psychosis IB Chaudhry, MO Husain, AB Khoso, MI Husain, MH Buch, T Kiran, B Fu, ... Translational Psychiatry 11, 2021 | 1 | 2021 |
Reduction in the use of seclusion in a high secure hospital in the UK: a retrospective analysis I Qurashi, D Johnson, B Johnson BMC Psychiatry 7 (Suppl 1), S121, 2007 | 1 | 2007 |